CVE:LBL Lattice Biologics (LBL) Stock Price, News & Analysis → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free LBL Stock Alerts C$0.04 0.00 (0.00%) (As of 06/3/2021) Add Compare Share Share Today's RangeC$0.04▼C$0.0450-Day RangeC$0.04▼C$0.0452-Week RangeC$0.03▼C$0.13Volume114,000 shsAverage Volume468,022 shsMarket CapitalizationC$5.13 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Lattice Biologics alerts: Email Address Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. About Lattice BiologicsLattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.Read More LBL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LBL Stock News HeadlinesJanuary 10, 2024 | seekingalpha.comIVBIY Innovent Biologics, Inc.May 7, 2023 | seekingalpha.comAbCellera Biologics GAAP EPS of -$0.14, revenue of $12MMarch 28, 2023 | benzinga.comADMA Biologics Stock (NASDAQ:ADMA), Analyst Ratings, Price Targets, PredictionsMarch 2, 2023 | investing.comLattice Biologics Ltd (LBLh)September 23, 2022 | markets.businessinsider.comLattice Announces Lattice Connect Partner Ecosystem to Help Organizations Maximize People SuccessSeptember 9, 2022 | morningstar.comLattice Semiconductor Corp LSCC Stock QuoteOctober 26, 2021 | finance.yahoo.comNotice of Lattice Biologics Ltd. Year End 2016 Financial Results Conference CallSee More Headlines Receive LBL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lattice Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:LBL CUSIPN/A CIKN/A Webwww.latticebiologics.com Phone+1-604-2356701FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.02 Quick Ratio0.02 Sales & Book Value Annual SalesC$1.56 million Price / Sales3.29 Cash FlowN/A Price / Cash FlowN/A Book ValueC$0.00 per share Price / Book40.00Miscellaneous Outstanding Shares128,218,000Free FloatN/AMarket CapC$5.13 million OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Guy S. Cook (Age 56)Chairman, Pres & CEO Comp: $360kMs. Donna MedinaInterim Chief Financial OfficerKey CompetitorsEntourage HealthCVE:ENTGHarvest One CannabisCVE:HVTDelta 9 CannabisTSE:DNEve & Co IncorporatedCVE:EVEAcerus PharmaceuticalsTSE:ASPView All Competitors LBL Stock Analysis - Frequently Asked Questions How have LBL shares performed in 2024? Lattice Biologics' stock was trading at C$0.04 at the start of the year. Since then, LBL stock has increased by 0.0% and is now trading at C$0.04. View the best growth stocks for 2024 here. What other stocks do shareholders of Lattice Biologics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Lattice Biologics investors own include Cross Timbers Royalty Trust (CRT), 50904 (GRC.V) (GRC), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Sorrento Therapeutics (SRNE), Arbor Realty Trust (ABR), Advanced Emissions Solutions (ADES) and Archer-Daniels-Midland (ADM). How do I buy shares of Lattice Biologics? Shares of LBL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:LBL) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lattice Biologics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.